CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent
Jingzhe Wang, Bakhos A. Tannous, Mark C. Poznansky, Huabiao Chen
Topics & Concepts
PlerixaforCXCR4 antagonistCXCR4MedicineCancer researchHaematopoiesisTumor microenvironmentLymphomaImmunologyImmune systemPharmacologyStem cellBiologyChemokineCell biologyChemokine receptors and signalingImmunotherapy and Immune ResponsesImmune Cell Function and Interaction